Lisa Warsinger Martin, MD, FACC

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Novartis ASTRONAUT multicenter trial finished >12 months ago(MODEST), Anthera - Cleveland Clinic trial - study site- finished >12 months ago(MODEST), Novartis - Harvard Hospitals- Brigham, I think- finished > 12 months ago(MODEST), Amarin Reduce-IT trial - EPA Omega 3 randomized trial for triglycerides-finished > 12 months ago(MODEST), Pfizer finished >12 months ago(MODEST), ROCHE -Daletrapib trial finished >12 months ago(MODEST)

View Full Disclosure